Tag: Diabetes

Categories

Eagle Biosciences Human Intact FGF23 CLEIA ELISA Used in Diabetes Study

by Eagle Biosciences

The Eagle Biosciences MedFrontier FGF23 (Human Intact FGF23) CLEIA ELISA Assay was used in a recently published study looking at the association between FGF23 levels and major adverse cardiovascular events (MACE) and mortality in patients with type 2 diabetes and normal or mildly impaired kidney function.

FGF23 is an endocrine hormone involved in vitamin D metabolism and phosphorous level regulation. Previous studies have shown a link between insulin resistance and an increase in FGF23, which researchers believe affects renal phosphorous handling and leads to a higher risk of MACE.

The study did find evidence of a connection with FGF23 levels and an increased risk of MACE or mortality in participating patients.

Read more about this study here.

Contact us for more information about this kit.

Study Citation:
Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function
Stanley M.H. Yeung, S. Heleen Binnenmars, Christina M. Gant, Gerjan Navis, Ron T. Gansevoort, Stephan J.L. Bakker, Martin H. de Borst, Gozewijn D. Laverman
Diabetes Care Sep 2019, dc190528; DOI: 10.2337/dc19-0528

Categories

Eating chocolate each day could reduce heart disease, diabetes risk

by Eagle Biosciences




A new study published in the British Journal of Nutrition appears to back up the adage that a little of what you fancy does you good.

Including a small amount of chocolate each day could help prevent diabetes and insulin resistance. That’s one of the research findings from the Luxembourg Institute of Health (LIH), the University of Warwick Medical School, the University of South Australia and the University of Maine. Read More

(Source: https://www.sciencedaily.com/releases/2016/04/160428124108.htm )

Categories

Reprogrammed Stomach Tissue as a Renewable Source of Functional β Cells for Blood Glucose Regulation

by Eagle Biosciences



Major progress has been made in recent years to produce functional insulin+ cells for cell replacement therapies to treat diabetes. These regenerative technologies include directed differentiation of embryonic stem cells and direct conversion from non-β cells such as liver cells, acinar cells, and others (Hebrok, 2012,Johannesson et al., 2015, Nostro and Keller, 2012, Schiesser and Wells, 2014,Zhou and Melton, 2008). Read more 

(Source: https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(16)00004-7)

Categories

Study: Obesity Surgery May Cure Diabetes

by Eagle Biosciences



A new study gives the strongest evidence yet that obesity surgery can cure diabetes. Patients who had surgery to reduce the size of their stomachs were five times more likely to see their diabetes disappear over the next two years than were patients who had standard diabetes care, according to Australian researchers.

(source: https://www.foxnews.com/story/2008/01/23/study-obesity-surgery-may-cure-diabetes.html)